Inflammatory Bowel Disease and Pregnancy: Moving Beyond Fear to Healthy Beginnings

For decades, women living with inflammatory bowel disease (IBD) were given daunting advice. In the mid-20th century, it was common for doctors to suggest that women with ulcerative colitis postpone motherhood indefinitely. For many, the choice seemed binary: treat the disease or have a healthy child.

Fortunately, we are no longer living in 1956. Today, the narrative has shifted from caution born of fear to empowerment through science. For the nearly one per cent of Canadians living with Crohn’s disease or ulcerative colitis, the dream of starting a family is not only possible but can be managed safely with the right medical partnership.

The Evolution of IBD Management in Pregnancy

The landscape of IBD care was revolutionized in the early 2000s with the introduction of biologics. These targeted therapies have allowed many patients to achieve lasting remission, healing the intestinal lining and restoring a quality of life that was previously unattainable.

Initially, doctors were cautious, often advising patients to stop medications late in pregnancy to avoid fetal exposure. However, evidence now shows that this approach often did more harm than good. Stopping medication frequently led to disease flares, which in turn increased the risk of pre-term birth and low birth weight.

The current medical consensus is clear: the health of the infant is inextricably linked to the health of the mother. Maintaining a state of remission is the most effective way to ensure a positive pregnancy outcome.

Understanding Medication Safety: What the Science Says

One of the biggest anxieties for expectant parents is whether IBD is hereditary. While there is a genetic component, the risk is often overestimated. For instance, if one parent has Crohn’s, the child’s risk is approximately one in ten—significantly lower for ulcerative colitis.

Regarding medication, the PIANO study (Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes), which tracked 1,700 pregnancies, revealed that most IBD medications do not increase the rates of birth defects or miscarriage. In fact, active inflammation is a much greater risk factor than the medication used to treat it.

Medication Cheat Sheet for IBD Pregnancies

• Generally Safe to Continue: Biologics, azathioprine, 6-mercaptopurine, and 5-aminosalicylic acid (5-ASA).
• Use with Caution: Corticosteroids. These are effective for active flares but should be used for the shortest time possible due to links with premature birth.
• Avoid Entirely: Methotrexate (must be stopped three months before conception), Janus kinase inhibitors, and sphingosine 1-phosphate receptor modulators.

The Importance of Preconception Planning

Because IBD is an immune-mediated disease, it interacts dynamically with the hormonal changes of pregnancy. While some autoimmune conditions improve during pregnancy, nearly 40 per cent of women with IBD experience flares. This makes the period before conception the most critical window for intervention.

An objective assessment of inflammation—via blood tests, stool samples, or imaging—is strongly recommended before trying to conceive. Ensuring the disease is inactive before pregnancy significantly reduces the likelihood of complications.

Modern Monitoring: The Rise of Intestinal Ultrasound

Monitoring IBD during pregnancy can be tricky because common pregnancy symptoms (nausea, abdominal pain, constipation) often mimic IBD flares. While blood work and stool tests are standard each trimester, new technology is providing deeper insights.

Intestinal ultrasound has emerged as a game-changer. This non-invasive tool allows gastroenterologists to check for bowel wall thickening at the bedside. Recent data suggests that a thick bowel wall in mid-pregnancy can predict a fourfold increase in the risk of premature birth, even if the mother feels perfectly healthy.

A Team Effort for a Healthy Future

If you are living with IBD and dreaming of a family, remember that you don’t have to navigate this alone. Success in these pregnancies is a “team sport.” The best outcomes occur when there is seamless communication between your gastroenterologist, obstetrician, and family doctor.

Don’t let outdated fears dictate your future. Reach out to your healthcare provider to create a personalized plan that prioritizes both your well-being and that of your future child.

Learn more about managing your condition: For comprehensive resources and support in Canada, visit Crohn’s & Colitis Canada or consult the latest guidelines on PubMed for peer-reviewed research on IBD and maternal health.